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Lung cancer is the primary cause of cancer 
related death in the world, in Europe and also in 
Poland. In spite of significant improvements in 
diagnosis and treatment over the last 10–20 years 
only modest increases in 5-year survival are being 
achieved. In Poland 5-year survival has increased 
from 11.4 to 13.4% , which is comparable to other 
European countries, but lower than the 18.7% 
achieved in the US and 30.1% in Japan. One of 
the main reasons for this is that lung cancer still 
in clinical practice in Europe is diagnosed in 
symptomatic and therefore mostly in advanced 
stages of the disease. Early diagnosis of lung 
cancer by low dose CT (LDCT) screening has the 
potential to fundamentally change this scenario. 
The results from the randomized National Lung 
Screening Trial (NLST) in the United States were 
remarkably clear to show an effect of CT screening 
on both lung cancer and all cause mortality. Ho-
wever the observed effect was the result of only 
three annual screenings. Therefore it is important 
to realize that the magnitude of the mortality re-
duction by continued annual CT screening over 
many years most likely would exceed that ob-
served in the NLST trial. During the last 15 years 
considerable evidence and experience with this 
method has been established. Poland has made 
important contributions to this field and almost 
50.000 individuals have so far participated in CT 
screening studies in Polish centers. It is therefore 
timely and appropriate that dr. Witold Rzyman 
and co-authors from 6 major centers in Poland, 
in this issue of ARM can publish a “Consensus 
statement on a screening programme for the de-
tection of early lung cancer in Poland”. 
The statement is very comprehensive and 
covers all the issues that need to be taken into 
account before implementation. It provides the 
relevant background knowledge on diagnosis 
and treatment of lung cancer, and the risks and 
expected outcomes of early detection of lung can-
cer using LDCT. The technical and organizational 
requirements for implementation of CT screening 
(equipment, radiation dose, nodule evaluation, 
quality control etc.) is described and discussed, 
and also the qualifications and performance 
of teams conducting the screening, including 
requirements for radiologists, pathologists and 
thoracic surgeons involved in the screening. The 
question of who should be screened is discussed 
and clear recommendations for inclusion crite-
ria and risk assessment are presented as well as 
a preliminary estimate of the costs associated with 
national implementation in Poland. 
The paper also emphasizes the need for 
lung cancer screening to be associated with an 
active smoking cessation program. A specific 
pathway for the smoking cessation intervention 
is described and this is a valuable tool in the 
implementation process in Poland which will 
increase the cost effectiveness of the screening 
program considerably. Lastly the inclusion of 
additional programmes for the detection of car-
diovascular disease (CAC score, Blood Pressure 
cholesterol) and COPD is described and recom-
mended. Although there are additional costs 
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associated with this, it is expected that these 
are manageable, and that in all this will incre-
ase the cost-effectiveness of the CT screening 
program further. 
The authors are to be congratulated with 
achieving this national consensus, which is very 
important for the future discussions on when 
and how to implement CT screening in Poland. 
This document will also be important for other 
countries in Europe as inspiration and guidance 
for national considerations on how to implement 
CT screening. 
